- Home
- AGL vs EOD Comparison
AGL vs EOD Comparison
Compare AGL & EOD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AGL | EOD |
|---|---|---|
| Founded | 2016 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Managed Health Care | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 270.4M | 252.4M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | AGL | EOD |
|---|---|---|
| Price | $0.77 | $5.91 |
| Analyst Decision | Hold | |
| Analyst Count | 17 | 0 |
| Target Price | ★ $2.77 | N/A |
| AVG Volume (30 Days) | ★ 5.8M | 118.1K |
| Earning Date | 02-24-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 9.28% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $5,885,571,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $2.82 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 5.21 | N/A |
| 52 Week Low | $0.51 | $3.73 |
| 52 Week High | $6.08 | $4.71 |
Technical Indicators
Market Signals| Indicator | AGL | EOD |
|---|---|---|
| Relative Strength Index (RSI) | 55.80 | 57.70 |
| Support Level | $0.67 | $5.82 |
| Resistance Level | $0.82 | $5.91 |
| Average True Range (ATR) | 0.05 | 0.07 |
| MACD | 0.01 | 0.00 |
| Stochastic Oscillator | 61.32 | 93.96 |
Price Performance
Historical ComparisonAbout AGL agilon health inc.
Agilon Health Inc is transforming healthcare by empowering primary care physicians for the health of the patients. The company enables physicians to create their own Medicare-centric globally capitated line of business. The company derives its revenue from Medical services.
About EOD Allspring Global Dividend Opportunity Fund of Beneficial Interest
Allspring Global Dividend Opportunity Fund is a diversified closed-end management investment company. Its primary investment objective is to seek a high level of current income. The fund's secondary objective is the long-term growth of capital. The fund allocates its assets between two separate investment strategies or sleeves. Under normal market conditions, the fund allocates approximately 80% of its total assets to an equity sleeve comprised of common stocks.